Pediatric Macrocorticotropinoma: Do They Differ from Microcorticotropinoma?

Abstract

<b><i>Introduction:</i></b> Cushing’s disease (CD) due to macrocorticotropinoma (MC) in children and adolescents is a rare entity with limited information regarding its characteristics. The objective of the study is to describe the clinical, biochemical, imaging, management, outcome, and genetic characteristics of children and adolescents with CD due to MC and compare them with those of microcorticotropinoma (mc). <b><i>Methods:</i></b> This retrospective study was conducted at a single tertiary care center. Thirty-two patients with CD and MC (maximum tumor dimension ≥10 mm on imaging) and 65 patients with mc (&lt;10 mm on imaging) aged ≤20 years at presentation were enrolled. <b><i>Results:</i></b> Nineteen girls and 13 boys with MC presented at a median (IQR) age of 14.5 (12.0–17.9) years. Patients with MC had higher body mass index-standard deviation score (BMI-SDS) (3.70 ± 2.60 vs. 2.59 ± 2.01, <i>p</i> = 0.04), more frequent neuro-ophthalmic symptoms (25% vs. 9% <i>p</i> = 0.04) and short stature (59% vs. 34%, <i>p</i> = 0.049) but less frequent livid striae (53% vs. 77%, <i>p</i> = 0.01), hypokalemia (12% vs. 36%, <i>p</i> = 0.04), and lower cortisol (nmol/L) to corticotropin (pmol/L) ratio (41.20 vs. 55.74, <i>p</i> = 0.04) than those with mc. The remission (59% vs. 64%, <i>p</i> = 1.0) and relapse (53% vs. 37%, <i>p</i> = 0.26) rates after first-line surgery and remission rate after radiotherapy (RT) were comparable between the two cohorts, whereas time to remission after RT (27 vs. 13 months, <i>p</i> = 0.05) was longer in the MC group. A patient with MC had a pathogenic germline variant in <i>CDH23</i>. <b><i>Conclusion:</i></b> In this large monocentric series of pediatric CD, frequent mass effect symptoms and short stature, higher BMI-SDS, less frequent livid striae, and hypokalemia with lower effective cortisol secretion characterize the MC cohort. The outcomes of surgery and RT were similar between the groups except for a longer time to remission after RT in the MC cohort. Germline variants are rare (4%) in pediatric MC.